Literature DB >> 31575546

HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma.

Baharan Fekry1, Aleix Ribas-Latre1, Corrine Baumgartner1, Alaa M T Mohamed1, Mikhail G Kolonin1,2, Frances M Sladek3, Mamoun Younes4, Kristin L Eckel-Mahan5,2.   

Abstract

The incidence of hepatocellular carcinoma (HCC) is on the rise worldwide. Although the incidence of HCC in males is considerably higher than in females, the projected rates of HCC incidence are increasing for both sexes. A recently appreciated risk factor for HCC is the growing problem of nonalcoholic fatty liver disease, which is usually associated with obesity and the metabolic syndrome. In this study, we showed that under conditions of fatty liver, female mice were more likely to develop HCC than expected from previous models. Using an inducible knockout model of the tumor-suppressive isoform of hepatocyte nuclear factor 4 alpha ("P1-HNF4α") in the liver in combination with prolonged high fat (HF) diet, we found that HCC developed equally in male and female mice as early as 38 weeks of age. Similar sex-independent HCC occurred in the "STAM" model of mice, in which severe hyperglycemia and HF feeding results in rapid hepatic lipid deposition, fibrosis, and ultimately HCC. In both sexes, reduced P1-HNF4α activity, which also occurs under chronic HF diet feeding, increased hepatic lipid deposition and produced a greatly augmented circadian rhythm in IL6, a factor previously linked with higher HCC incidence in males. Loss of HNF4α combined with HF feeding induced epithelial-mesenchymal transition in an IL6-dependent manner. Collectively, these data provide a mechanism-based working hypothesis that could explain the rising incidence of aggressive HCC. SIGNIFICANCE: This study provides a mechanism for the growing incidence of hepatocellular carcinoma in both men and women, which is linked to nonalcoholic fatty liver disease. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31575546      PMCID: PMC6881553          DOI: 10.1158/0008-5472.CAN-19-1277

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

Review 1.  Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.

Authors:  Catherine Cavard; Sabine Colnot; Virginie Audard; Samira Benhamouche; Laetitia Finzi; Cyril Torre; Gisèle Grimber; Cécile Godard; Benoit Terris; Christine Perret
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

Review 2.  Maturity onset diabetes of the young: identification and diagnosis.

Authors:  Tim J McDonald; Sian Ellard
Journal:  Ann Clin Biochem       Date:  2013-07-22       Impact factor: 2.057

3.  IRE1α-XBP1 signaling pathway regulates IL-6 expression and promotes progression of hepatocellular carcinoma.

Authors:  Peipei Fang; Luxia Xiang; Shanshan Huang; Lingxiang Jin; Guangyao Zhou; Lu Zhuge; Jie Li; Hengwei Fan; Lingli Zhou; Chenwei Pan; Yi Zheng
Journal:  Oncol Lett       Date:  2018-07-19       Impact factor: 2.967

4.  Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.

Authors:  Karthikeyani Chellappa; Poonamjot Deol; Jane R Evans; Linh M Vuong; Gang Chen; Nadege Briançon; Eugene Bolotin; Christian Lytle; Meera G Nair; Frances M Sladek
Journal:  Elife       Date:  2016-05-11       Impact factor: 8.140

Review 5.  A balance of interleukin-12 and -23 in cancer.

Authors:  Shin Foong Ngiow; Michele W L Teng; Mark J Smyth
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

6.  Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon.

Authors:  Wendy D Garrison; Michele A Battle; Chuhu Yang; Klaus H Kaestner; Frances M Sladek; Stephen A Duncan
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.

Authors:  Chad Walesky; Genea Edwards; Prachi Borude; Sumedha Gunewardena; Maura O'Neil; Byunggil Yoo; Udayan Apte
Journal:  Hepatology       Date:  2013-06       Impact factor: 17.425

8.  Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies.

Authors:  Yuqin Wang; Baochan Wang; Feng Shen; Jiangao Fan; Haixia Cao
Journal:  Oncologist       Date:  2012-09-06

9.  Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.

Authors:  Guilherme Ribeiro Romualdo; Gabriel Bacil Prata; Tereza Cristina da Silva; Ana Angélica Henrique Fernandes; Fernando Salvador Moreno; Bruno Cogliati; Luís Fernando Barbisan
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

10.  Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.

Authors:  Marcus Grohmann; Florian Wiede; Garron T Dodd; Esteban N Gurzov; Geraldine J Ooi; Tariq Butt; Aliki A Rasmiena; Supreet Kaur; Twishi Gulati; Pei K Goh; Aislinn E Treloar; Stuart Archer; Wendy A Brown; Mathias Muller; Matthew J Watt; Osamu Ohara; Catriona A McLean; Tony Tiganis
Journal:  Cell       Date:  2018-10-25       Impact factor: 41.582

View more
  7 in total

1.  Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer.

Authors:  Kai Wang; Yiran Wei; Ruijuan Xu; Yiyi Li; Cungui Mao
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.

Authors:  Philippe Lefebvre; Bart Staels
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

3.  Adipose tissue-specific ablation of Ces1d causes metabolic dysregulation in mice.

Authors:  Gang Li; Xin Li; Li Yang; Shuyue Wang; Yulin Dai; Baharan Fekry; Lucas Veillon; Lin Tan; Rebecca Berdeaux; Kristin Eckel-Mahan; Philip L Lorenzi; Zhongming Zhao; Richard Lehner; Kai Sun
Journal:  Life Sci Alliance       Date:  2022-04-22

Review 4.  Circadian Genes as Therapeutic Targets in Pancreatic Cancer.

Authors:  María García-Costela; Julia Escudero-Feliú; Jose D Puentes-Pardo; Sara Moreno San Juán; Sonia Morales-Santana; Sandra Ríos-Arrabal; Ángel Carazo; Josefa León
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-11       Impact factor: 5.555

5.  HNF4A defines tissue-specific circadian rhythms by beaconing BMAL1::CLOCK chromatin binding and shaping the rhythmic chromatin landscape.

Authors:  Meng Qu; Han Qu; Zhenyu Jia; Steve A Kay
Journal:  Nat Commun       Date:  2021-11-03       Impact factor: 14.919

Review 6.  Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.

Authors:  Vanessa Dubois; Bart Staels; Philippe Lefebvre; Michael P Verzi; Jérôme Eeckhoute
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

Review 7.  Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).

Authors:  Pin Zhao; Samiullah Malik; Shaojun Xing
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.